ANKTIVA THE NK CELL GROWTH FACTOR
Live / Allowed — Published for opposition (as of 14 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Dec 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99527269
- Mark type
- Slogan / phrase
- Filed
- 03 Dec 2025
- Published for opposition
- 14 Jul 2026
- Attorney of record
- Alicia M. Passerin
Goods and services
- Class 005 — Pharmaceuticals: Medicinal preparations for the treatment and prevention of cancer and infectious diseases; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the prevention of cancer; Biological preparations for the prevention and treatment of cancer and infectious diseases; Vaccines
Owner
- ImmunityBio, Inc., San Diego, CA, US
- ImmunityBio, Inc., San Diego, CA, US
Prosecution history
- 14 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jul 2026 — PUBLISHED FOR OPPOSITION
- 08 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Mar 2026 — NON-FINAL ACTION E-MAILED
- 16 Mar 2026 — NON-FINAL ACTION WRITTEN
- 13 Mar 2026 — ASSIGNED TO EXAMINER
- 03 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 03 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Dec 2025 — NEW APPLICATION ENTERED